GRHPR Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of GRHPR Antibodies for research focused on understanding the glyoxylate and dicarboxylate metabolism pathway. GRHPR Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GRHPR plays a vital role in converting glyoxylate to glycine, significantly impacting amino acid metabolism and detoxification processes. Proper GRHPR function maintains metabolic balance in biological systems. Dysregulation of GRHPR has been associated with several metabolic disorders. Research into GRHPR expression and activity patterns continues to reveal new insights about metabolic conditions. Understanding GRHPR function aids in developing targeted therapeutic approaches for metabolic diseases. GRHPR research using Santa Cruz Biotechnology monoclonal antibodies enables scientists to advance our understanding of metabolic health and disease mechanisms.